Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure

被引：0
|
作者：
Vasyuk, Yu. A.
Yuschuk, E. N.
Shkolnik, E. L.
Khadzegova, A. B.
Sadulaeva, I. A.
Vitko, N. X.
Vakhromeeva, M. N.
机构：
来源：
TERAPEVTICHESKII ARKHIV | 2007年 / 79卷 / 02期
关键词：
chronic heart failure; myocardial metabolism; hybernation; trimethasidine MB; 3-(2,2,2-trimethylhydrasinium) propionate dihydrate; positron-emission tomography;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 58
页数：8
相关论文
共 50 条
  • [21] Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE)
    Tanaka, Atsushi
    Hisauchi, Itaru
    Taguchi, Isao
    Sezai, Akira
    Toyoda, Shigeru
    Tomiyama, Hirofumi
    Sata, Masataka
    Ueda, Shinichiro
    Oyama, Jun-ichi
    Kitakaze, Masafumi
    Murohara, Toyoaki
    Node, Koichi
    ESC HEART FAILURE, 2020, 7 (04): : 1585 - 1594
  • [22] EFFECTS OF D,L-CARNITINE AND 3-(2,2,2-TRIMETHYL HYDRAZINIUM) PROPIONATE AS INHIBITOR OF GAMMA-BUTYROBETAINE HYDROXYLASE ON ISOPROTERENOL-INDUCED ALTERATIONS IN MYOCARDIUM METABOLISM
    SIMKHOVICH, BZ
    MEIRENA, DV
    SHUTENKO, ZV
    HAGI, HB
    BRIEDE, YL
    KALVINSH, IY
    LUKEVICS, EY
    VOPROSY MEDITSINSKOI KHIMII, 1988, 34 (05): : 30 - 34
  • [23] Effects of Canagliflozin in Patients With Type 2 Diabetes and Chronic Heart Failure: A Randomized Clinical Trial (CANDLE)
    Tanaka, Atsushi
    Hisauchi, Itaru
    Taguchi, Isao
    Sezai, Akira
    Toyoda, Shigeru
    Sata, Masataka
    Ueda, Shinichiro
    Oyama, Jun-ichi
    Kitakaze, Masafumi
    Murohara, Toyoaki
    Node, Koichi
    CIRCULATION, 2019, 140
  • [24] The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 x 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
    Wiggers, Henrik
    Kober, Lars
    Gislason, Gunnar
    Schou, Morten
    Poulsen, Mikael Kjaer
    Vraa, Soren
    Nielsen, Olav Wendelbo
    Bruun, Niels Eske
    Norrelund, Helene
    Hollingdal, Malene
    Barasa, Anders
    Bottcher, Morten
    Dodt, Karen
    Hansen, Vibeke Brogaard
    Nielsen, Gitte
    Knudsen, Anne Sejr
    Lomholdt, Jens
    Mikkelsen, Kirsten Vilain
    Jonczy, Bartlomiej
    Bronnum-Schou, Jens
    Poenaru, Monica Petronela
    Abdulla, Jawdat
    Raymond, Ilan
    Mahboubi, Kiomars
    Sillesen, Karen
    Serup-Hansen, Kristine
    Madsen, Jette Sandberg
    Kristensen, Soren Lund
    Larsen, Anders Hostrup
    Botker, Hans Erik
    Torp-Petersen, Christian
    Eiskjaer, Hans
    Moller, Jacob
    Hassager, Christian
    Steffensen, Flemming Hald
    Bibby, Bo Martin
    Refsgaard, Jens
    Hofsten, Dan Eik
    Mellemkjaer, Soren
    Gustafsson, Finn
    AMERICAN HEART JOURNAL, 2021, 231 : 137 - 146
  • [25] Comparison of carvedilol and bisoprolol efficacy in patients with chronic heart failure and diabetes types 2 after myocardial infarction
    Statsenko, M. E.
    Belenkova, S. V.
    Sporova, O. E.
    Ivanova, D. A.
    Evtereva, E. D.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2008, 4 (02) : 30 - 33
  • [26] Comparative Analysis of Antioxidant Activity of Nebivolol in Patients With Chronic Heart Failure With and Without Concomitant Type 2 Diabetes
    Belenkov, Yu. N.
    Privalova, E. V.
    Chekneva, I. S.
    Zheleznykh, E. A.
    Knyazeva, L. V.
    Azizova, O. A.
    Aseytchev, A. V.
    Baranova, O. A.
    Shvachko, A. G.
    KARDIOLOGIYA, 2011, 51 (01) : 5 - 10
  • [27] The crystal and molecular structure of cobalt(III) ethylenediamine-N,N'-diacetate-N,N'-di-3-propionate(3-) dihydrate [Co(HEdda)]center dot 2H(2)O
    Antsyshkina, AS
    Sadikov, GG
    Shkolnikova, LM
    Poznyak, AL
    Sergienko, VS
    ZHURNAL NEORGANICHESKOI KHIMII, 1996, 41 (09): : 1463 - 1469
  • [28] Acute and chronic therapeutic impact of a vasopressin 2 antagonist in congestive heart failure (ACTIV in CHF): A placebo-controlled trial in patients hospitalized with heart failure
    Gheorghiade, M
    O'Connor, CM
    Adams, KF
    Gattis, WA
    Barbagelata, A
    Elkayam, U
    McGrew, F
    Ghali, JK
    Benza, RL
    Klapholz, M
    Orlandi, C
    CIRCULATION, 2003, 108 (21)
  • [29] Utilization and Efficacy of Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure ― A Report From the CHART-2 Study ―
    Hayashi, Hideka
    Yasuda, Satoshi
    Nakano, Makoto
    Sakata, Yasuhiko
    Nochioka, Kotaro
    Shiroto, Takashi
    Hasebe, Yuhi
    Noda, Takashi
    Miyata, Satoshi
    Shimokawa, Hiroaki
    CIRCULATION REPORTS, 2022, 4 (06) : 264 - 273
  • [30] COMPARATIVE EFFECTS OF 2 CONVERTING-ENZYME INHIBITORS ON RENAL-FUNCTION IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE - A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL
    PACKER, M
    LEE, WH
    MEDINA, N
    YUSHAK, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A70 - A70
12345